These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 30958071)

  • 21. Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery: a meta-analysis and trial sequential analysis of randomized trials.
    Xing Z; Tang L; Chen P; Huang J; Peng X; Hu X
    Sci Rep; 2018 May; 8(1):7775. PubMed ID: 29773835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use.
    Papp Z; Agostoni P; Alvarez J; Bettex D; Bouchez S; Brito D; Černý V; Comin-Colet J; Crespo-Leiro MG; Delgado JF; Édes I; Eremenko AA; Farmakis D; Fedele F; Fonseca C; Fruhwald S; Girardis M; Guarracino F; Harjola VP; Heringlake M; Herpain A; Heunks LMA; Husebye T; Ivancan V; Karason K; Kaul S; Kivikko M; Kubica J; Masip J; Matskeplishvili S; Mebazaa A; Nieminen MS; Oliva F; Papp JG; Parissis J; Parkhomenko A; Põder P; Pölzl G; Reinecke A; Ricksten SE; Riha H; Rudiger A; Sarapohja T; Schwinger RHG; Toller W; Tritapepe L; Tschöpe C; Wikström G; Lewinski DV; Vrtovec B; Pollesello P
    J Cardiovasc Pharmacol; 2020 Jul; 76(1):4-22. PubMed ID: 32639325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN).
    Moiseyev VS; Põder P; Andrejevs N; Ruda MY; Golikov AP; Lazebnik LB; Kobalava ZD; Lehtonen LA; Laine T; Nieminen MS; Lie KI;
    Eur Heart J; 2002 Sep; 23(18):1422-32. PubMed ID: 12208222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levosimendan And Septic Cardiomyopathy: A Key That May Have Found Its Lock?
    Radosevich M; Couture EJ; Nabzdyk C
    J Cardiothorac Vasc Anesth; 2023 Mar; 37(3):350-352. PubMed ID: 36609077
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of levosimendan on myocardial contractility, coronary and peripheral blood flow, and arrhythmias during coronary artery ligation and reperfusion in the in vivo pig model.
    du Toit E; Hofmann D; McCarthy J; Pineda C
    Heart; 2001 Jul; 86(1):81-7. PubMed ID: 11410569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decompensated congestive heart failure - treatment with levosimendan.
    Buzzini RF; Silvinato A; Floriano I; Bernardo WM; Almeida GR
    Rev Assoc Med Bras (1992); 2019 May; 65(4):524-529. PubMed ID: 31066804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melatonin: A potential protective multifaceted force for sepsis-induced cardiomyopathy.
    Casper E; El Wakeel L; Sabri N; Khorshid R; Fahmy SF
    Life Sci; 2024 Jun; 346():122611. PubMed ID: 38580195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term effects of levosimendan on strain/strain rate markers in patients with nonischemic dilated cardiomyopathy.
    Kırış T; Avcı E
    J Clin Ultrasound; 2018 Oct; 46(8):527-532. PubMed ID: 30229927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levosimendan: A promising agent for the treatment of hospitalized patients with decompensated heart failure.
    Lehtonen L
    Curr Cardiol Rep; 2000 May; 2(3):233-43. PubMed ID: 10980898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction.
    Huang L; Weil MH; Tang W; Sun S; Wang J
    Crit Care Med; 2005 Mar; 33(3):487-91. PubMed ID: 15753736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levosimendan improves diastolic and systolic function in failing human myocardium.
    Janssen PM; Datz N; Zeitz O; Hasenfuss G
    Eur J Pharmacol; 2000 Sep; 404(1-2):191-9. PubMed ID: 10980279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential Effects of Levosimendan and Dobutamine on Glomerular Filtration Rate in Patients With Heart Failure and Renal Impairment:A Randomized Double-Blind Controlled Trial.
    Lannemyr L; Ricksten SE; Rundqvist B; Andersson B; Bartfay SE; Ljungman C; Dahlberg P; Bergh N; Hjalmarsson C; Gilljam T; Bollano E; Karason K
    J Am Heart Assoc; 2018 Aug; 7(16):e008455. PubMed ID: 30369310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inotropic and lusitropic effects of levosimendan and milrinone assessed by strain echocardiography-A randomised trial.
    Fredholm M; Jörgensen K; Houltz E; Ricksten SE
    Acta Anaesthesiol Scand; 2018 Oct; 62(9):1246-1254. PubMed ID: 29926912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levosimendan as bridge to transplant in patients with advanced heart failure.
    Ponz de Antonio I; de Juan Bagudá JS; Rodríguez Chaverri A; García-Cosío Carmena MD; Arribas Ynsaurriaga F; Delgado Jiménez JF
    Rev Esp Cardiol (Engl Ed); 2020 May; 73(5):422-424. PubMed ID: 32061565
    [No Abstract]   [Full Text] [Related]  

  • 35. [Myocardial dysfunction during sepsis: epidemiology, prognosis and treatment].
    Paoli G; Valente S; Ardissino D; Gensini GF
    G Ital Cardiol (Rome); 2011 Dec; 12(12):804-14. PubMed ID: 22158451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ambulatory levosimendan infusions. Effective and efficient in advanced heart failure?
    Dobarro D; Ribera-Solé A
    Rev Esp Cardiol (Engl Ed); 2020 May; 73(5):345-347. PubMed ID: 32107145
    [No Abstract]   [Full Text] [Related]  

  • 37. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.
    Kivikko M; Lehtonen L
    Curr Pharm Des; 2005; 11(4):435-55. PubMed ID: 15725064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved myocardial function with supplement of levosimendan to Celsior solution.
    Zhou HY; Zhang LN; Zheng MZ; Wang LL; Chen YY; Shen YL
    J Cardiovasc Pharmacol; 2014 Sep; 64(3):256-65. PubMed ID: 24785343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats.
    Louhelainen M; Vahtola E; Forsten H; Merasto S; Kytö V; Finckenberg P; Leskinen H; Kaheinen P; Tikkanen I; Levijoki J; Mervaala E
    J Hypertens; 2009 Oct; 27(10):2094-107. PubMed ID: 19730126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.
    Hummel J; Rücker G; Stiller B
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011312. PubMed ID: 28262914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.